104 related articles for article (PubMed ID: 21824258)
1. Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexia.
Jensen PB; Larsen PJ; Karlsen C; Jensen HI; Holst JJ; Madsen OD
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():60-8. PubMed ID: 21824258
[TBL] [Abstract][Full Text] [Related]
2. Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.
Jensen PB; Blume N; Mikkelsen JD; Larsen PJ; Jensen HI; Holst JJ; Madsen OD
J Clin Invest; 1998 Jan; 101(2):503-10. PubMed ID: 9435324
[TBL] [Abstract][Full Text] [Related]
3. Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia.
Madsen OD; Karlsen C; Blume N; Jensen HI; Larsson LI; Holst JJ
Scand J Clin Lab Invest Suppl; 1995; 220():27-35. PubMed ID: 7652479
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Tang-Christensen M; Vrang N; Larsen PJ
Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
[TBL] [Abstract][Full Text] [Related]
5. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness.
Kinzig KP; D'Alessio DA; Seeley RJ
J Neurosci; 2002 Dec; 22(23):10470-6. PubMed ID: 12451146
[TBL] [Abstract][Full Text] [Related]
6. The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable alpha- and beta-cell tumor phenotypes.
Madsen OD; Karlsen C; Nielsen E; Lund K; Kofod H; Welinder B; Rehfeld JF; Larsson LI; Steiner DF; Holst JJ
Endocrinology; 1993 Nov; 133(5):2022-30. PubMed ID: 8404649
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide containing pathways in the regulation of feeding behaviour.
Tang-Christensen M; Vrang N; Larsen PJ
Int J Obes Relat Metab Disord; 2001 Dec; 25 Suppl 5():S42-7. PubMed ID: 11840214
[TBL] [Abstract][Full Text] [Related]
8. The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice.
Lachey JL; D'Alessio DA; Rinaman L; Elmquist JK; Drucker DJ; Seeley RJ
Endocrinology; 2005 Jan; 146(1):458-62. PubMed ID: 15459118
[TBL] [Abstract][Full Text] [Related]
9. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
[TBL] [Abstract][Full Text] [Related]
10. Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.
Punjabi M; Arnold M; Rüttimann E; Graber M; Geary N; Pacheco-López G; Langhans W
Endocrinology; 2014 May; 155(5):1690-9. PubMed ID: 24601880
[TBL] [Abstract][Full Text] [Related]
11. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the brainstem preproglucagon system in the obese Zucker rat.
Vrang N; Larsen PJ; Jensen PB; Lykkegaard K; Artmann A; Larsen LK; Tang-Christensen M
Brain Res; 2008 Jan; 1187():116-24. PubMed ID: 18022140
[TBL] [Abstract][Full Text] [Related]
13. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
[TBL] [Abstract][Full Text] [Related]
14. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.
Rinaman L
Am J Physiol; 1999 Nov; 277(5):R1537-40. PubMed ID: 10564228
[TBL] [Abstract][Full Text] [Related]
15. Gut satiety hormones cholecystokinin and glucagon-like Peptide-1
Zhang J; Liu S; Zhang H; Li Y; Wu W; Zhang H
Toxicol Appl Pharmacol; 2017 Nov; 335():49-55. PubMed ID: 28964791
[TBL] [Abstract][Full Text] [Related]
16. Do glucagonomas always produce glucagon?
Wewer Albrechtsen NJ; Challis BG; Damjanov I; Holst JJ
Bosn J Basic Med Sci; 2016 Feb; 16(1):1-7. PubMed ID: 26773171
[TBL] [Abstract][Full Text] [Related]
17. Potential roles for glucagon-like peptide-1
Wu W; Sheng K; Xu X; Zhang H; Zhou G
Ecotoxicol Environ Saf; 2018 May; 153():181-187. PubMed ID: 29433086
[TBL] [Abstract][Full Text] [Related]
18. Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker DJ; Erlich P; Asa SL; Brubaker PL
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7911-6. PubMed ID: 8755576
[TBL] [Abstract][Full Text] [Related]
19. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
Seeley RJ; Blake K; Rushing PA; Benoit S; Eng J; Woods SC; D'Alessio D
J Neurosci; 2000 Feb; 20(4):1616-21. PubMed ID: 10662851
[TBL] [Abstract][Full Text] [Related]
20. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
